Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


URETHRAL OBSTRUCTION side effect

What is URETHRAL OBSTRUCTION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   URETHRAL OBSTRUCTION and Recently Reported Side Effects   URETHRAL OBSTRUCTION and 15 most Active Side Effect polls   URETHRAL OBSTRUCTION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with URETHRAL OBSTRUCTION

ERBITUX  LEUKINE  NUVARING  VESICARE  VIVACTIL  


Leukine Side Effects Report #5730144-3
Health Professional from UNITED STATES reported LEUKINE problem on May 05, 2008. Male patient, 64 years of age, weighting 275.6 lb, was diagnosed with prostate cancer and was treated with LEUKINE. After drug was administered, patient experienced the following problems/side effects: urethral obstruction, urethral stenosis, urinary incontinence, . LEUKINE dosage: unknown. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5736494-9
ERBITUX problem was reported by a Health Professional from UNITED STATES on May 08, 2008. Female patient, 46 years of age, weighting 103.6 lb, was diagnosed with adenocarcinoma of the cervix and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, urethral obstruction, . ERBITUX dosage: START DATE:29FEB08;CYCLE 1, D1 LOADING DOSE 400 MG/M2 IV. SUBSEQUENT DOSES: 250 MG/M2 IV ON D1 + D8. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Vesicare Side Effects Report #5368483-0
Health Professional from UNITED STATES reported VESICARE problem on June 04, 2007. Male patient, 32 years of age, weighting 154.3 lb, was diagnosed with neurogenic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: bladder neck obstruction, urethral obstruction, . VESICARE dosage: 10 MG, UID/QD, ORAL. Patient was hospitalized and became disabled. Patient recovered.

Vesicare Side Effects Report #5324447-4
VESICARE problem was reported by a Health Professional from UNITED KINGDOM on Apr 23, 2007. Male patient, 32 years of age, weighting 154.3 lb, was diagnosed with neurogenic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: catheter related complication, urethral obstruction, . VESICARE dosage: 10 MG, ORAL. Patient was hospitalized. Patient recovered.


Vivactil Side Effects Report #5405004-8
Health Professional from UNITED STATES reported VIVACTIL problem on July 18, 2007. Male patient, 55 years of age, was diagnosed with pain and was treated with VIVACTIL. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, condition aggravated, urethral obstruction, urinary retention, . VIVACTIL dosage: 5 MG, TID, ORAL. Patient recovered.

Erbitux Side Effects Report #5760905-6
ERBITUX problem was reported by a Health Professional from UNITED STATES on June 03, 2008. Female patient, 46 years of age, weighting 103.6 lb, was diagnosed with adenocarcinoma of the cervix and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, haemoglobin decreased, urethral obstruction, . ERBITUX dosage: START DATE:29FEB08;CYCLE 1, D1 LOADING DOSE 400 MG/M2 IV. SUBSEQUENT DOSES: 250 MG/M2 IV ON D1 + D8. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Nuvaring Side Effects Report #5757814-5
Consumer or non-health professional from FRANCE reported NUVARING problem on May 19, 2008. Female patient, 18 years of age, was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: pelvic pain, urethral haemorrhage, urethral obstruction, . NUVARING dosage: unknown. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about URETHRAL OBSTRUCTION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about URETHRAL OBSTRUCTION